Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling.

Nat Commun, 2014/3/25;5:3472.

Chen WJ[1], Ho CC[2], Chang YL[3], Chen HY[4], Lin CA[5], Ling TY[6], Yu SL[5], Yuan SS[4], Chen YJ[4], Lin CY[4], Pan SH[7], Chou HY[8], Chen YJ[9], Chang GC[10], Chu WC[11], Lee YM[11], Lee JY[11], Lee PJ[11], Li KC[12], Chen HW[13], Yang PC[14]

Affiliations

PMID: 24668028DOI: 10.1038/ncomms4472

Impact factor: 17.694

Abstract
Cancer stem cells (CSCs) are a promising target for treating cancer, yet how CSC plasticity is maintained in vivo is unclear and is difficult to study in vitro. Here we establish a sustainable primary culture of Oct3/4(+)/Nanog(+) lung CSCs fed with CD90(+) cancer-associated fibroblasts (CAFs) to further advance our knowledge of preserving stem cells in the tumour microenvironment. Using transcriptomics we identify the paracrine network by which CAFs enrich CSCs through de-differentiation and reacquisition of stem cell-like properties. Specifically, we find that IGF1R signalling activation in cancer cells in the presence of CAFs expressing IGF-II can induce Nanog expression and promote stemness. Moreover, this paracrine signalling predicts overall and relapse-free survival in stage I non-small cell lung cancer (NSCLC) patients. IGF-II/IGF1R signalling blockade inhibits Nanog expression and attenuates cancer stem cell features. Our data demonstrate that CAFs constitute a supporting niche for cancer stemness, and targeting this paracrine signalling may present a new therapeutic strategy for NSCLC.
MeSH terms
More resources
EndNote: Download